Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Total Assets of $396.90 million for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $396.90M | +13.1% |
| 2024 | $350.91M | -25.5% |
| 2023 | $471.07M | -57.2% |
| 2022 | $1.10B | -2.3% |
| 2021 | $1.13B | +101.5% |
| 2020 | $559.24M | +38.9% |
| 2019 | $402.75M | +21.3% |
| 2018 | $332.05M | -45.2% |
| 2017 | $605.67M | -14.7% |
| 2016 | $709.82M | +14.6% |
| 2015 | $619.12M | +88.0% |
| 2014 | $329.32M | +18.1% |
| 2013 | $278.96M | +21.3% |
| 2012 | $229.91M | +10.0% |
| 2011 | $208.98M | -30.7% |
| 2010 | $301.37M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $396.06M | +1.7% | +15.5% |
| June 30, 2025 | $342.95M | -13.3% | +4.8% |
| March 31, 2025 | $327.21M | -25.4% | -6.8% |
| December 31, 2024 | $350.91M | -25.5% | -9.9% |
| September 30, 2024 | $389.52M | -25.7% | -1.5% |
| June 30, 2024 | $395.62M | -34.4% | -9.8% |
| March 31, 2024 | $438.82M | -62.0% | -6.8% |
| December 31, 2023 | $471.07M | -57.2% | -10.1% |
- IRONWOOD PHARMACEUTICALS INC showed an increase of +13.1% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, IRONWOOD PHARMACEUTICALS INC’s total assets has grown by 31.7% (from $301.37 million to $396.90 million).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: